BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1632 related articles for article (PubMed ID: 32479787)

  • 21. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
    Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of baseline clinical and HRCT findings in 101 patients with severe COVID-19 in Wuhan, China.
    Cao Y; Han X; Gu J; Li Y; Liu J; Alwalid O; Cui Y; Zhang X; Zheng C; Fan Y; Wu H; Shi H
    Sci Rep; 2020 Oct; 10(1):17543. PubMed ID: 33067524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
    Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
    Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.
    Shi M; Chen L; Yang Y; Zhang J; Xu J; Xu G; Li B; Yin Y
    J Clin Lab Anal; 2020 Sep; 34(9):e23415. PubMed ID: 32488958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
    Shi S; Qin M; Shen B; Cai Y; Liu T; Yang F; Gong W; Liu X; Liang J; Zhao Q; Huang H; Yang B; Huang C
    JAMA Cardiol; 2020 Jul; 5(7):802-810. PubMed ID: 32211816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, China.
    Chen L; Liu S; Tian J; Pan H; Liu Y; Hu J; Wang M; Hou X
    Immun Inflamm Dis; 2020 Dec; 8(4):584-594. PubMed ID: 32857453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of COVID-19 disease severity in patients with cancer.
    Robilotti EV; Babady NE; Mead PA; Rolling T; Perez-Johnston R; Bernardes M; Bogler Y; Caldararo M; Figueroa CJ; Glickman MS; Joanow A; Kaltsas A; Lee YJ; Lucca A; Mariano A; Morjaria S; Nawar T; Papanicolaou GA; Predmore J; Redelman-Sidi G; Schmidt E; Seo SK; Sepkowitz K; Shah MK; Wolchok JD; Hohl TM; Taur Y; Kamboj M
    Nat Med; 2020 Aug; 26(8):1218-1223. PubMed ID: 32581323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
    Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
    Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.
    Wang D; Yin Y; Hu C; Liu X; Zhang X; Zhou S; Jian M; Xu H; Prowle J; Hu B; Li Y; Peng Z
    Crit Care; 2020 Apr; 24(1):188. PubMed ID: 32354360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.
    Mitra AR; Fergusson NA; Lloyd-Smith E; Wormsbecker A; Foster D; Karpov A; Crowe S; Haljan G; Chittock DR; Kanji HD; Sekhon MS; Griesdale DEG
    CMAJ; 2020 Jun; 192(26):E694-E701. PubMed ID: 32461326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.
    Zhang J; Wang X; Jia X; Li J; Hu K; Chen G; Wei J; Gong Z; Zhou C; Yu H; Yu M; Lei H; Cheng F; Zhang B; Xu Y; Wang G; Dong W
    Clin Microbiol Infect; 2020 Jun; 26(6):767-772. PubMed ID: 32304745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
    Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
    Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
    Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
    JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.